|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 211 - 240 of 334 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
PL
|
Resepti
|
Diovan 40 mg, 80 mg, 160 mg, 320 mg tabletti, kalvopäällysteinen SPC 2024-08-07
|
PL
|
Resepti
|
Diovan Comp 80mg-12.5mg, 160mg-12.5mg, 160mg-25mg, 320mg-12.5mg, 320mg-25mg tabletti, kalvopäällysteinen SPC 2020-08-31
|
PL
|
Resepti
|
Diovan Comp 80mg-12.5mg, 160mg-12.5mg, 160mg-25mg, tabletti, kalvopäällysteinen SPC 2022-02-08
|
PL
|
Resepti
|
Diovan Comp 80mg-12.5mg, 160mg-12.5mg, 160mg-25mg, tabletti, kalvopäällysteinen SPC 2022-02-08
|
PL
|
Resepti
|
Diovan Comp 80mg-12.5mg, 160mg-12.5mg, 160mg-25mg, tabletti, kalvopäällysteinen SPC 2022-02-08
|
PL
|
Resepti
|
Dipentum 250 mg kapseli SPC 2019-03-15
|
PL
|
Resepti
|
Dipentum 250 mg kapseli, kova SPC 2022-08-23
|
PL
|
Resepti
|
Dipeptiven 200 mg-ml infuusiokonsentraatti SPC 2023-02-17
|
PL
|
Resepti
|
Diprosalic 0,5 mg-g - 20 mg-g voide SPC 2021-04-26
|
PL
|
Resepti
|
Diprosalic 0,5 mg-g _ 20 mg-g liuos iholle SPC 2021-04-26
|
PL
|
Itsehoito
|
Disperin 100 mg tabletti SPC 2024-05-02
|
PL
|
Itsehoito
|
Disperin 500 mg tabletti SPC 2024-05-02
|
PL
|
Resepti
|
diTeBooster injektioneste, suspensio, esitäytetty ruisku SPC 2023-05-11
|
PL
|
Resepti
|
diTekiBooster injektioneste, suspensio, esitäytetty ruisku SPC 2024-07-12
|
PL
|
Resepti
|
Ditekipol injektioneste, suspensio SPC 2022-09-01
|
PL
|
Resepti
|
Ditrim duplo 16 mg-ml - 50 mg-ml oraalisuspensio SPC 2021-07-12
|
PL
|
Resepti
|
Ditrim duplo 160 mg - 500 mg tabletti SPC 2021-07-12
|
PL
|
Resepti
|
Ditustin 6 mg-ml oraaliliuos SPC 2023-09-12
|
PL
|
Resepti
|
Diuramin 5 mg-50 mg tabletti SPC 2022-04-28
|
PL
|
Resepti
|
Diuramin mite 2.5 mg-25 mg tabletti SPC 2022-04-28
|
PL
|
Resepti
|
Divifarm 1000 IU, 7000 IU, 30000 IU tabletti, kalvopäällysteinen SPC 2022-02-03
|
PL
|
Resepti
|
Divifarm 2000 IU tabletti, kalvopäällysteinen SPC 2023-05-10
|
PL
|
Resepti
|
Divifarm 800 IU tabletti, kalvopäällysteinen SPC 2022-02-03
|
PL
|
Resepti
|
Divigel 0,5 mg, 1 mg transdermaaligeeli, annospussi SPC 2024-06-12
|
PL
|
Resepti
|
Divigel 0.5mg 1mg transdermaaligeeli, annospussi SPC 2024-06-12.docx
|
PL
|
Resepti
|
Divina tabletti SPC 2023-06-21
|
PL
|
Resepti
|
Diviseq tabletti SPC 2001-02-12
|
PL
|
Resepti
|
Divisun 2000 IU tabletti SPC 2023-06-16
|
PL
|
Resepti
|
Divisun 800 IU tabletti SPC 2023-06-16
|
PL
|
Resepti
|
Diza 0.02 - 3 mg tabletti, kalvopäällysteinen SPC 2022-12-07
|
|
| |